Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 301 results
Press release cover image

Nov 4, 2026

Laza Medical Raises Up to $160 Million in Series B Financing Led by GE HealthCare to Advance Intelligent Imaging for Transforming the Cath Lab

Company's first-of-a-kind intelligent imaging system aims to expand patient access, streamline high-quality cardiac care, and establish the foundation for future robotic interventionsLOS GATOS, Calif., Nov. 4, 2026 /PRNewswire/ -- Laza Medical, Inc., a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning
Press release cover image

Nov 4, 2026

Lunit Presents AI-Powered Pathology Research in Ovarian and Bladder Cancers at SITC 2026

Studies with Labcorp and CellCarta identify proliferation-related tissue differences in HRD ovarian cancer and explore spatial immune features associated with immunotherapy response in bladder cancerSEOUL, South Korea, Nov. 4, 2026 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that it will present two collaborative studies with Labcorp and CellCarta using its AI-powered pathology platform, Lunit SCOPE, at the Society
Press release cover image

Nov 4, 2026

Sectra Reporting brings imaging, AI, and radiology reporting together in one system at Mount Sinai Health System

LINKÖPING, Sweden, Nov. 4, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed an agreement with Mount Sinai Health System in New York to deliver Sectra Reporting, the native reporting module in Sectra's enterprise imaging solution, Sectra One Cloud. Mount Sinai's radiologists will go from worklist to signed report in one seamless experience, without switching between systems, helping shorten report turnaround times."Radiologists read t
Press release cover image

Nov 3, 2026

ELUCIDATE Study Demonstrates 93 Percent Accuracy with Strong Performance in the “Gray Zone” for Elucid’s FDA-cleared FFR-IQ™

Data presented at TCT 2026 demonstrate highest sensitivity and specificity of any FFR-CT validation studyBOSTON & SAN DIEGO--(BUSINESS WIRE)--#CCTA--Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at the annual Transcatheter Cardiovascular Therapeutics Conference (TCT 2026). The ELUCIDATE study, which supported Elucid’s recent U.S. Food and Drug Administration (FDA) 510(k) clearance of the FFR-IQTM software, demonstrated 9
Press release cover image

Nov 3, 2026

Surgical Planning Associates Expands HipInsight System's Open Platform with Five Additional Orthopedic Implant Systems

Expanded 3D preoperative planning library gives surgeons greater implant choice across primary and revision total hip arthroplastyTORONTO, Nov. 3, 2026 /PRNewswire/ -- Surgical Planning Associates (SPA), a medical technology company specializing in preoperative planning and navigation solutions for joint arthroplasty, today announced the addition of five implant systems to the preoperative 3D planning library of its HipInsight System®, including more triple taper stem systems.The expansion inclu
A minimalist illustration of a heart and MRI scan in dark colors.

Nov 3, 2026

AI predicts patient survival from cardiac MRI scans better than clinicians

Recent research indicates that AI-driven analyses of cardiac MRI scans significantly enhance predictions of patient survival compared to traditional clinician assessments, suggesting a transformative role for AI in cardiac care.The study, conducted by City St George’s, University of London, and University College London, focused on ejection fraction, a critical measure of heart function that informs treatment decisions for patients with heart disease. Analyzing MRI scans from over 27,000 patient
A minimalist illustration of a lung and CT scan slice in dark colors with lime accents.

Nov 2, 2026

Brainomix Says Biomarker Qualification Is Next Step For Its FDA-Cleared Lung AI Software

Brainomix is advancing its FDA-cleared e-Lung software towards biomarker qualification, following promising results from Boehringer Ingelheim’s Phase III INBUILD trial.Recent findings from a substudy involving 474 patients indicate that CT-derived imaging biomarkers can effectively identify individuals at risk of disease progression and assess the efficacy of antifibrotic treatments. The study highlighted that both the e-Lung system from Brainomix and a research algorithm from UCLA successfully
Press release cover image

Nov 2, 2026

Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset

Expanded Human-Submitted Image Review Shows Image-Quality Pass Rate of 86%, Body-Map Registration of 89% and Change-Over-Time Alignment of 91% MESA, AZ / ACCESS Newswire / November 2, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that updated internal evaluation results for MDCE Melanoma Scan Beta have been posted on the Company's corporate website.The full technical summary is available at https://www.medicalcaretechnologies.com. This release fulfills the Company's October
Press release cover image

Nov 2, 2026

TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI’s AVC Solution

TIME Best Inventions 2026Nanox.AI's Investigational AVC Solution Demonstrated 98.3% Sensitivity and 96.6% Specificity in Evaluable CT Scans.Findings Highlight the Potential of AI to Identify Previously Unreported Aortic Valve Calcification Using Existing Routine CT Scans.Findings published in the peer-reviewed journal JACC: Advances. PETACH TIKVA, Israel, Nov. 2, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox” or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technolog
Press release cover image

Nov 2, 2026

Neurophet and RapidAI Partner to Expand Access to Alzheimer's and MS Treatment Monitoring

- Agreement expands Neurophet's reach into U.S. health systems and builds on RapidAI's leadership in enterprise clinical AI and neurosciencesSEOUL, South Korea, Nov. 2, 2026 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, today announced a partnership with RapidAI, a global leader in enterprise clinical AI, to integrate Neurophet's advanced neurodegenerative brain imaging solutions into the Rapid Enterprise Platform.Continu
Press release cover image

Nov 2, 2026

Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution

SUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced the commercial launch of its delirium monitoring solution on its point-of-care brain monitoring platform. Ceribell combines seizure detection and delirium monitoring in a single system using one headband, leveraging proprietary AI-power
A minimalist representation of a tissue sample for cancer research.

Nov 2, 2026

EPFL launches spora, an open tissue atlas for cancer AI

EPFL has unveiled spora, a groundbreaking open tissue atlas aimed at enhancing AI research in cancer diagnostics and treatment.Launched in collaboration with institutions in Zurich and Geneva, spora is touted as the largest freely accessible spatial proteomics atlas in the world. This innovative resource contains over 13,500 multiplex images derived from nearly 5,500 patients, encompassing data from 14 different tissue types and utilizing five imaging technologies. The comprehensive dataset not